Company news
Kpc Pharmaceuticals, Inc. Class A (SSE:600422) news
Kpc Pharmaceuticals, Inc. Class A news releases on 6ix. Latest, Sep 12, 2026: "KPC PHARMACEUTICALS, INC."Announcement on Resolutions of the 2nd Extraordinary…
Press releases & updates
"KPC PHARMACEUTICALS, INC."Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026
September 11, 2026
"KPC PHARMACEUTICALS, INC."Announcement on Receipt of the Notice of Registration Acceptance from the National Association of Financial Market Institutional Investors
September 1, 2026
"KPC PHARMACEUTICALS, INC."Announcement on Convening the 2026 Semi-annual Performance Briefing
August 27, 2026
"KPC PHARMACEUTICALS, INC."Announcement on Amendments to the Articles of Association
August 21, 2026
"KPC PHARMACEUTICALS, INC."Announcement on Resolutions of the 21st Meeting of the 11th Board of Directors
July 24, 2026
"KPC PHARMACEUTICALS, INC."Announcement on Implementation of Dividend Distribution for 2025
July 21, 2026
"KPC PHARMACEUTICALS, INC."Semi-annual Performance Forecast for 2026
July 14, 2026
"KPC PHARMACEUTICALS, INC."Announcement on Inclusion of the Company's Products in the "National Essential Medicines List (2026 Edition)"
July 10, 2026
Announcement on Resolutions of the 20th Meeting of the 11th Board of Directors
June 29, 2026
Announcement on Remuneration Plan for Directors and Senior Management Members in 2026
June 8, 2026
Indicative Announcement on Controlling Shareholder's Equity Change Reaching 1% Scale
May 14, 2026
Report for Q1 2026
April 24, 2026
Announcement on Obtaining Drug Registration Certificate
April 20, 2026
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
April 17, 2026
Announcement on Change of Senior Management Member
March 31, 2026
Indicative Announcement on the Publication of the 2025 Performance Announcement by CR Pharmaceutical Group Co., Ltd., an Indirectly Controlling Shareholder of the Controlling Shareholder
March 25, 2026
Notice on Convening the 1st Extraordinary General Meeting in 2026
March 23, 2026
Announcement on Change of Partial Directors and Senior Management Members
March 19, 2026
Preliminary Earnings Estimate for 2025
February 6, 2026
Announcement on Resignation of Director
January 7, 2026
Announcement on Change of Chairman
January 5, 2026
Announcement on Resolutions of the 12th Meeting of the 11th Board of Directors
December 30, 2025
Announcement on Resolutions of the 5th Extraordinary General Meeting in 2025
December 29, 2025
Announcement on Progress in External Guarantees
December 22, 2025
Announcement on Resolutions of the 11th Meeting of the 11th Board of Directors
December 9, 2025
Announcement on Convening the Q3 2025 Performance Briefing
October 28, 2025
Announcement on Resolutions of the 9th Meeting of the 11th Board of Directors
October 24, 2025
Announcement on Resolutions of the 4th Extraordinary General Meeting in 2025
October 10, 2025
Announcement on Using Idle Own Funds for Investment and Wealth Management Business
September 17, 2025
Announcement on Convening the 2025 Semi-annual Performance Briefing
August 20, 2025
2025 Semi-annual Report
August 15, 2025
Announcement on Implementation of Dividend Distribution for 2024
July 21, 2025
Announcement on Progress in External Guarantee
June 24, 2025
Announcement on Resolution of the 6th Meeting of the 11th Board of Directors
June 23, 2025
Announcement on Resolution of the 2024 Annual General Meeting
June 20, 2025
Notice on Convening the 2024 Annual General Meeting
May 29, 2025
Announcement on Convening the Q1 2025 Performance Briefing
May 21, 2025
Announcement on Attending the 2024 Online Collective Reception Day for Investors of Listed Companies in Yunnan Jurisdiction
May 12, 2025
Announcement on Resolution of the 4th Meeting of the 11th Board of Directors
April 28, 2025
Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025
April 18, 2025
Announcement on Resignation of Senior Management Member
March 27, 2025
Indicative Announcement on Publication of 2024 Annual Performance Announcement by Indirect Controlling Shareholder China Resources Pharmaceutical Group Limited of Controlling Shareholder
March 26, 2025
Announcement on 2025 Guarantee Plan
March 25, 2025
Announcement on Resolution of the 2nd Meeting of the 11th Board of Directors
March 11, 2025
Announcement on Obtaining Drug Clinical Trial Approval Notification
February 28, 2025
Announcement on Resolution of the 2nd Extraordinary General Meeting in 2025
February 13, 2025
Announcement on Preliminary Earnings Estimate for 2024
February 10, 2025
Announcement on the Provision of Online Voting Reminder Service for the General Meeting
February 7, 2025
Announcement on Increasing Idle Self-owned Funds for Investment and Financial Business
January 22, 2025
Indicative Announcement on the Acceptance of New Drug Application
January 14, 2025